Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce its acquisition of Evoke Neuroscience, Inc. (“Evoke”), a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain health. The transaction marks another important step toward Firefly building a proprietary foundation model of the human brain using its FDA-cleared Brain Network Analytics (“BNA™”) technology.
Read the full article: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. //
Source: https://www.globenewswire.com/news-release/2025/05/05/3073967/0/en/Firefly-Neuroscience-Achieves-Multi-Fold-Database-IP-Portfolio-and-Commercial-Footprint-Expansion-Through-Acquisition-of-Evoke-Neuroscience-Inc.html